会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 42. 发明授权
    • Anthracycline derivatives, their preparation and use
    • 蒽环类衍生物,其制备和用途
    • US4327029A
    • 1982-04-27
    • US2072
    • 1979-01-08
    • Luigi BernardiPaolo MasiAntonino SuaratoFederico Arcamone
    • Luigi BernardiPaolo MasiAntonino SuaratoFederico Arcamone
    • A61K31/65A61K31/70A61K31/7028A61K31/7034A61K31/704A61P35/00C07H15/252C07C39/40
    • C07H15/252Y10S514/908
    • Compounds of the formula: ##STR1## wherein R.sub.1 is a C.sub.2 -C.sub.4 alkyl; a C.sub.3 -C.sub.6 cycloalkyl or benzyl; A and B are OH or A and B are OCOOR.sub.4 or B is OH and A is OCOOR.sub.4 ; and R.sub.4 is alkyl which are intermediates for the preparation of antitumor compounds of the formula: ##STR2## wherein R.sub.1 is a C.sub.2 -C.sub.4 alkyl; a C.sub.3 -C.sub.6 cycloalkyl; a C.sub.3 -C.sub.6 cycloalkyl substituted by a halogen, hydroxy, methoxy, amino or dimethylamino group; phenyl or phenyl substituted with nitro, chlorine or methoxy thiazyl, pyridyl, pyrazyl; or a phenyl-alkyl group of the formula X--Phe--(CH.sub.2).sub.n --, in which X is hydrogen, halogen, hydroxyl, amino, or nitro and n is an integer from 1 to 2; R.sub.2 is hydrogen, hydroxyl or acyloxy (R--COO--); where R is an alkyl having from 1 to 11 carbon atoms; and R.sub.3 is hydrogen or trifluoroacetyl and salts thereof with pharmaceutically acceptable acids.
    • 下式的化合物:其中R 1是C 2 -C 4烷基; C3-C6环烷基或苄基; A和B是OH或A,B是OCOOR4或B是OH,A是OCOOR4; 和R4是作为制备下式的抗肿瘤化合物的中间体的烷基:其中R 1是C 2 -C 4烷基; C3-C6环烷基; 被卤素,羟基,甲氧基,氨基或二甲氨基取代的C3-C6环烷基; 苯基或被硝基,氯或甲氧基噻唑取代的苯基,吡啶基,吡嗪基; 或式X-Phe-(CH2)n-的苯基 - 烷基,其中X是氢,卤素,羟基,氨基或硝基,n是1至2的整数; R2是氢,羟基或酰氧基(R-COO-); 其中R是具有1至11个碳原子的烷基; 并且R 3是氢或三氟乙酰基及其盐与药学上可接受的酸。
    • 44. 发明授权
    • Anthracycline derivatives, their preparation and use
    • 蒽环类衍生物,其制备和用途
    • US4166848A
    • 1979-09-04
    • US850933
    • 1977-11-14
    • Luigi BernardiPaolo MasiAntonino SuaratoFederico Arcamone
    • Luigi BernardiPaolo MasiAntonino SuaratoFederico Arcamone
    • A61K31/65A61K31/70A61K31/7028A61K31/7034A61K31/704A61P35/00C07H15/252C07G3/00C07G11/00
    • C07H15/252Y10S514/908
    • Disclosed are antitumor compounds of the formula: ##STR1## wherein R.sub.1 is a C.sub.2 -C.sub.4 alkyl; a C.sub.3 -C.sub.6 cycloalkyl; a C.sub.3 -C.sub.6 cycloalkyl substituted by a halogen, hydroxy, methoxy, amino or dimethylamino group; phenyl or phenyl substituted with nitro, chlorine or methoxy; thiazyl, pyridyl, pyrazyl; or a phenyl-alkyl group of the formula X--Phe--(CH.sub.2).sub.n --, in which X is hydrogen, halogen, hydroxyl, amino, or nitro and n is an integer from 1 to 2; R.sub.2 is hydrogen, hydroxyl or acyloxy (R--COO--), where R is an alkyl having from 1 to 11 carbon atoms; and R.sub.3 is hydrogen or trifluoroacetyl and salts thereof with pharmaceutically acceptable acids. Compounds I are prepared by condensing the aglycones thereof with 2,3,6-trideoxy-3-trifluoroacetamido-4-O-trifluoro-acetyl-.alpha.-L-lyxopyranosyl chloride according to a conventional technique.
    • 公开了下式的抗肿瘤化合物:其中R 1是C 2 -C 4烷基; C3-C6环烷基; 被卤素,羟基,甲氧基,氨基或二甲氨基取代的C3-C6环烷基; 苯基或被硝基,氯或甲氧基取代的苯基; 噻嗪基,吡啶基,吡嗪基; 或式X-Phe-(CH2)n-的苯基 - 烷基,其中X是氢,卤素,羟基,氨基或硝基,n是1至2的整数; R2是氢,羟基或酰氧基(R-COO-),其中R是具有1至11个碳原子的烷基; 并且R 3是氢或三氟乙酰基及其盐与药学上可接受的酸。 通过根据常规技术将其糖苷配基与2,3,6-三脱氧-3-三氟乙酰氨基-4-O-三氟乙酰基-β-L-吡喃葡糖酰氯缩合制备化合物I.
    • 46. 发明授权
    • Process for preparing cephalosporins and intermediates
    • 制备头孢菌素和中间体的方法
    • US4012381A
    • 1977-03-15
    • US586376
    • 1975-06-12
    • Maurizio FoglioGiovanni FranceschiPaolo MasiAntonino Suarato
    • Maurizio FoglioGiovanni FranceschiPaolo MasiAntonino Suarato
    • C07D205/095C07D501/08C07D501/18C07D501/20
    • C07D205/095
    • A process is disclosed for preparing derivatives of 7-amino-cephalosporanic acid and 7-amino-desacetoxycephalosporanic acid of structure: starting from a 3-acylamino-2.beta.-thiohydrazoazetidinone of structure: ##STR1## wherein the compound (II') is reacted with a phosphorous halide in the presence of a tertiary amine, the corresponding imino chloride is reacted with a lower aliphatic alcohol, the iminoether so formed is hydrolyzed with water in an acid medium, and the resultant 3-amino-2.beta.-thiohydrazoazetidinone of structure: ##STR2## is reacted in a suitable solvent and at a temperature between -100.degree. and +120.degree. C with a compound selected from the class consisting of inorganic basic or weakly acid oxides and inorganic and organic bases, to finally give the desired compound (V) which is isolated and purified in known manner.2.beta.-thiohydrazoazetidinones are also disclosed as intermediates.
    • 公开了一种制备以下结构的3-氨基 - 头孢烷酸和7-氨基 - 脱乙酰氧基头孢烷酸的衍生物的方法,其结构如下:起始于结构如下的3-酰基氨基-2β-硫代代氮杂环丁酮:(II' ),其中化合物(II')在叔胺存在下与卤化磷反应,相应的亚氨基氯与低级脂族醇反应,所形成的亚氨基醚在酸性介质中用水水解,得到的 将结构如下的3-氨基-2β-硫代代代氮杂环丁酮在合适的溶剂中,在-100至+ 120℃的温度下与选自无机碱性或弱碱性的化合物反应 酸性氧化物和无机和有机碱,最终得到所需的化合物(V),其以已知方式分离和纯化。